KUALA LUMPUR: Carlsberg Bewery Malaysia Bhd’s prospects of an earnings recovery remains on track in anticipation of a full-blown roll-out of the vaccination programme in the second half of the year.

Following the brewer’s latest earnings results, Kenanga Research said it expects the near-term weakness resulting from softer beer demand to be partially alleviated by a sturdier Singapore operation due to the improving Covid situation there.

“After rolling over valuation base to FY22E, we revised down our TP to RM24.10 applying a lower PER of 25.0x (implying 0.5SD below mean) to reflect the resurgence of near term head-winds.

Read the full article.

JOIN OUR FREE NEWSLETTER

Remain an expert and save time ? Take few seconds to complete the registration form. Click here !